Jorge is a Strategic Partner at Evolution Venture Partners. Jorge heads up EVP's Molecular Diagnostics activities.
Dr. Jorge Leon is internationally recognized for his pioneering work in molecular diagnostics. Dr. Leon holds a Ph.D. in cellular and molecular biology from New York University, and completed his postdoctoral studies at the German Cancer Research Center in Heidelberg and Columbia University in NYC. Dr. Leon’s subsequent academic research focused on developing monoclonal antibody-based tumor marker assays and radio-immuno imaging devices, which are currently in wide use.
In the early 1990s, Dr. Jorge Leon transitioned into industry, playing an integral role in establishing and leading the molecular diagnostics laboratories at Quest Diagnostics. As Director of Molecular Diagnostics, Senior Director of Biotechnology Development, and Vice President of Applied Genomics, Dr. Leon spent twelve years developing Quest’s molecular diagnostics strategy, which is now the world’s largest molecular diagnostics service laboratory.
In 2003, Dr. Leon founded Leomics Associates, Inc. a consulting firm committed to helping develop molecular diagnostics and personalized medicine (pharmacogenomics) in the United States and globally. Dr. Jorge Leon and his experienced team specializes in identifying breakthrough opportunities and industry trends, and helps start-up businesses, academic centers and established companies successfully build and commercialize innovative business strategies, product pipelines, and test menus.